Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond J Monnat

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Nature Communications|July 7, 2026
Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancerScott Best, Daniel S Hippe, Eli Grunblatt, et al.
Scientific Reports|March 10, 2017
Homozygosity for the WRN Helicase-Inactivating Variant, R834C, does not confer a Werner syndrome clinical phenotypeAshwini S Kamath-Loeb, Diego G Zavala-van Rankin, Jeny Flores-Morales, et al.
Plos One|October 14, 2014
MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trialThomas Pavelitz, Lindsay Renfro, Nathan R Foster, et al.
The Journal of Biological Chemistry|February 24, 2007
The Werner syndrome helicase is a cofactor for HIV-1 long terminal repeat transactivation and retroviral replicationAnima Sharma, Soumya Awasthi, Carolyn K Harrod, et al.
Nature Structural & Molecular Biology|February 12, 2013
Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibitionMatteo Berti, Arnab Ray Chaudhuri, Saravanabhavan Thangavel, et al.
Molecular and Cellular Biology|July 1, 2005
A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactionsSoumya Awasthi, Anima Sharma, Kasuen Wong, et al.
Gastroenterology|May 27, 2014
CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancerStacey Shiovitz, Monica M Bertagnolli, Lindsay A Renfro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2016
WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based TherapyLinda J W Bosch, Yanxin Luo, Victoria V Lao, et al.
International Journal of Cancer|March 13, 2023
Fanconi anemia-isogenic head and neck cancer cell line pairs: A basic and translational science resourceHiep Tai Nguyen, Weiliang Tang, Andrew L H Webster, et al.
Nature Reviews. Cancer|May 31, 2020
Tumour predisposition and cancer syndromes as models to study gene-environment interactionsMichele Carbone, Sarah T Arron, Bruce Beutler, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Nature Communications|July 7, 2026
Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancerScott Best, Daniel S Hippe, Eli Grunblatt, et al.
Scientific Reports|March 10, 2017
Homozygosity for the WRN Helicase-Inactivating Variant, R834C, does not confer a Werner syndrome clinical phenotypeAshwini S Kamath-Loeb, Diego G Zavala-van Rankin, Jeny Flores-Morales, et al.
Plos One|October 14, 2014
MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trialThomas Pavelitz, Lindsay Renfro, Nathan R Foster, et al.
The Journal of Biological Chemistry|February 24, 2007
The Werner syndrome helicase is a cofactor for HIV-1 long terminal repeat transactivation and retroviral replicationAnima Sharma, Soumya Awasthi, Carolyn K Harrod, et al.
Nature Structural & Molecular Biology|February 12, 2013
Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibitionMatteo Berti, Arnab Ray Chaudhuri, Saravanabhavan Thangavel, et al.
Molecular and Cellular Biology|July 1, 2005
A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactionsSoumya Awasthi, Anima Sharma, Kasuen Wong, et al.
Gastroenterology|May 27, 2014
CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancerStacey Shiovitz, Monica M Bertagnolli, Lindsay A Renfro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2016
WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based TherapyLinda J W Bosch, Yanxin Luo, Victoria V Lao, et al.
International Journal of Cancer|March 13, 2023
Fanconi anemia-isogenic head and neck cancer cell line pairs: A basic and translational science resourceHiep Tai Nguyen, Weiliang Tang, Andrew L H Webster, et al.
Nature Reviews. Cancer|May 31, 2020
Tumour predisposition and cancer syndromes as models to study gene-environment interactionsMichele Carbone, Sarah T Arron, Bruce Beutler, et al.
Pageof 9